GLP-1 Agonists (Semaglutide, Tirzepatide) GLP-1 receptor agonists like semaglutide and tirzepatide produce fat loss primarily through appetite suppression and reduced caloric intake rather than direct fat cell targeting
Adaptable for Recovery & Stress Models Ideal for studies on post-exertion recovery, inflammation control, and stress resilience
Animal studies have revealed that secondary bile acids may impair the integrity of the BBB
The peptides compensate for age-related decline in natural healing factors, helping older adults recover from injuries at rates closer to younger individuals
A novel pentadecapeptide, BPC 157, blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine
Involved in amino acid transport and maintenance of protein sulfhydryl reduction status